BioSpace News Archive

BioMidwest

BioStem Technologies Closes Oversubscribed $2M Private Placement

BioStem Technologies Inc. announces that it has closed an oversubscribed private placement of common stock to accredited investors for an aggregate of 1,337,000 units at a price of $1.50 per Unit for gross proceeds of $2 million.

November 3, 2023
·
4 min read
Business

Oncocyte to Announce Third Quarter 2023 Financial Results

Oncocyte Corporation, a precision diagnostics company, announced that the company will host a conference call and webcast on Thursday, November 9, 2023, at 5:00 a.m. Pacific Time / 8:00 a.m. Eastern Time to discuss its third quarter financial results and recent highlights.

November 3, 2023
·
1 min read
Policy

BriaCell Reports Unprecedented Anti-Tumor Activity of its Next Generation Personalized Breast and Prostate Cancer Immunotherapies in Tumor Models at the 2023 SITC Annual Meeting; FDA Greenlights Bria-OTS™ IND

Therapeutics Corp. is pleased to report unprecedented activity of its next generation, personalized, off-the-shelf, cell-based breast and prostate cancer immunotherapies at the 2023 Society for Immunotherapy of Cancer annual meeting.

November 3, 2023
·
8 min read
BioMidwest

Align Technology to Speak at Upcoming Financial Conferences - November 03, 2023

Align Technology, Inc. announced that the company is scheduled to speak at the following upcoming financial conferences.

November 3, 2023
·
2 min read
Biotech Bay

Cerus Corporation to Participate in Upcoming November 2023 Investor Conferences

Cerus Corporation announced that the Company will participate in two upcoming investor conferences.

November 3, 2023
·
1 min read
Biotech Bay

Mirum Pharmaceuticals to Present at the 2023 UBS Biopharma Conference

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that it is scheduled to participate in a fireside chat at the 2023 UBS Biopharma Conference on Wednesday, November 8th 2023 at 2:00 pm ET, as well as 1x1 meetings.

November 3, 2023
·
2 min read
Business

Quoin Pharmaceuticals Announces Third Quarter 2023 Financial Results and Corporate Update Conference Call to be held on Thursday November 9th at 8:30 am ET

Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage specialty pharmaceutical company focused on rare and orphan diseases, announced today that the Company plans to release its third quarter 2023 financial results after the market closes on Wednesday, November 8, 2023.

November 3, 2023
·
1 min read
Business

Lexicon Pharmaceuticals to Host Third Quarter 2023 Financial Results Conference Call and Webcast on November 8, 2023

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) will release its third quarter 2023 financial results on Wednesday, November 8th, 2023 before the markets open.

November 3, 2023
·
3 min read
Genetown

Hopewell Therapeutics Announces Oral and Poster Presentations at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting

Hopewell Therapeutics today announced it will have both an oral and a poster presentation on preclinical data from the Company’s Oncology programs at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting, being held November 1 - 5, 2023, in San Diego, California.

November 3, 2023
·
2 min read
Pharm Country

Verismo Therapeutics Announces Upcoming Presentation at SITC 2023

Verismo Therapeutics, a clinical-stage CAR-T company developing novel KIR-CAR platform technology today announced that it will be presenting at the upcoming Society for Immunotherapy of Cancer 38th Annual Meeting (SITC 2023), to be held in San Diego and virtually November 1-5, 2023.

November 3, 2023
·
2 min read